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Abstract An anti-chlorpropham single-chain variable-fragment
(scFv) gene was introduced into Arabidopsis in a manner to
express the antibody fragment in each of four di¡erent subcel-
lular compartments. The accumulation of scFv in transgenic
plants was detected by targeting the fragment in the endoplas-
mic reticulum or apoplastic space, or by expressing the frag-
ment as a glycosylphosphatidylinositol-anchored protein, while
no accumulation could be detected by targeting the fragment in
the cytosol. Transgenic plants accumulating the scFv gene at a
high level in the endoplasmic reticulum had enhanced tolerance
to chlorpropham in comparison with the non-transformants.
 2003 Published by Elsevier B.V. on behalf of the Federation
of European Biochemical Societies.
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1. Introduction
Many reports in recent years have described the expression
of antibodies or antibody fragments in plants [1]. They have
proven the e¡ectiveness of this technique for modulating phy-
tohormone activity [2^4], in blocking plant-pathogen infection
[5], and in producing vaccines [6]. Recombinant antibodies
such as Fab and single-chain variable fragments (scFv) as
well as original antibodies have been used in this technique.
ScFv is the minimum recombinant antibody with antigen-
binding activity, in which the variable regions of the heavy
and light chains are connected by a £exible linker peptide
[7,8]. Since scFv is encoded by a single structural gene, it
can be more easily produced in plants than the complete anti-
body.
The development of herbicide-tolerant plants has been
achieved in di¡erent ways to increase the weed control in
crops. Most of them have so far been transformed with genes
isolated from microorganisms or plants. However, alternative
methods are needed to meet the requirements for other herbi-
cides. The e¡ectiveness of anti-herbicide antibody expression
has been suggested by the exogenous application of an anti-
diuron antibody to isolated thylakoids or green algae that
were protected from photosynthetic inhibition by the herbi-
cide [9].
We have previously succeeded in producing scFv against
chlorpropham (isopropyl-N-(3-chlorophenyl) carbamate) in
Escherichia coli [10]. Chlorpropham, a pre-emergence herbi-
cide, can be used for the control of weeds and as a sprout
suppressant on potatoes [11]. We report here the preparation
of transgenic plants expressing anti-chlorpropham scFv as a
new approach to developing herbicide-tolerant plants. The
expression of scFv and protection from chlorpropham-depen-
dent inhibition were optimized by its accumulation in di¡erent
cellular compartments, using ¢ve plant expression vector con-
structs. First, a plant expression vector harboring the scFv
gene was designed to retain scFv in the lumen of the endo-
plasmic reticulum (ER), where stable and high-level expres-
sion of antibodies has been shown [2]. Second, the scFv
expression was targeted in the cytosol (CY), where chlor-
propham action is supposed to take place. Third, scFv was
expressed in a secreted form by targeting scFv via ER to the
apoplastic space (AP). The expression of scFv as a glycosyl-
phosphatidylinositol (GPI)-anchored protein was also exam-
ined. GPI is a type of lipid membrane anchor containing a
conserved glycan linkage covalently attached to the C-termi-
nus of a protein, with phosphatidylinositol, which is em-
bedded in the outer layer of the plasma membrane, attaching
the protein to the plasma membrane [12]. Takos et al. have
recently reported that GPI-addition signals derived from yeast
and a plant functioned to link a GPI anchor to a reporter
protein in plant cells [13]. In this present study, we expressed
scFv as a GPI-anchored protein by using GPI-addition signals
isolated from Arabidopsis thaliana AtAGP5 or Saccharomyces
cerevisiae GAS1.
We ¢nally tested the tolerance of transgenic plants to chlor-
propham. The relationship between the tolerance and the ex-
pression level or subcellular localization of scFv is also dis-
cussed.
2. Materials and methods
2.1. Construction of the plant expression vectors
Five vectors incorporating the anti-chlorpropham scFv gene were
constructed for plant transformation (Fig. 1). The scFv gene was
ampli¢ed by polymerase chain reaction (PCR) to create restriction
enzyme sites and a KDEL sequence, and was replaced with the
GUS reporter gene of binary vector pBI121 [14], which contains a
kanamycin-resistance gene, CaMV 35S promoter and nopaline syn-
thase terminator, between the left and right borders of the T-DNA,
giving the plant expression vector pBISCY. To construct pBISER, the
PCR product was fused to the 5P end of the legumine B4 signal se-
quence (LeB4) in pRTRA15 [2], and the resulting fusion gene was
cloned into pBI121. pBISAP was constructed by fusing LeB4 to the
PCR product without the KDEL sequence in the same way as used
for pBISER construction. pBISGA and pBISGS were respectively
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constructed by fusing the GPI-addition signals isolated from Arabi-
dopsis AtAGP5 or S. cerevisiae GAS1 [14] to the 3P end resulting from
the fusion of scFv and LeB4, and by inserting the resulting fusion
genes in pBI121.
2.2. Plant transformation
pBISER, pBISCY, pBISAP, pBISGA and pBISGS were introduced
into Agrobacterium tumefaciens strain GV3010 (pMP90), which was
used to transform Arabidopsis plants (A. thaliana ecotype Columbia)
as previously described [15]. Transgenic plants were selected on Mur-
ashige^Skoog (MS) agar medium containing 100 Wg/ml of kanamycin.
The independent T1 transformants are identi¢ed by number (#) as
AER#, ACY#, AAP#, AGA# and AGS# from respective constructs
pBISER, pBISCY, pBISAP, pBISGA and pBISGS. Each T2 plant is
identi¢ed by another number like AER#-#. The homozygous T3 lines
were selected by segregation for their kanamycin resistance.
2.3. ELISA and Western blotting
Whole plants were frozen in liquid nitrogen and ground to a ¢ne
powder, and proteins were extracted from the powder with phos-
phate-bu¡ered saline (PBS).
The expression and binding activity of scFv in the transgenic plants
toward chlorpropham were detected by enzyme-linked immunosorb-
ent assay (ELISA) as previously described [10]. Indirect ELISA
(i-ELISA) was performed by successively incubating the following
solutions: 100 Wl of chlorpropham hapten conjugated with rabbit
serum albumin (2 Wg/ml in 50 mM NaHCO3, pH 9.6) at 4‡C for
16 h as the plate-coating antigen, 200 Wl of 2% skim milk in PBS
for blocking at 25‡C for 2 h, 100 Wl of the protein extract containing
300 Wg of bovine serum albumin-equivalent protein at 25‡C for 1 h,
100 Wl of the anti-c-myc antibody (9E10 mouse ascites 1000 times
diluted with PBS) [16], 100 Wl of the horseradish peroxidase (HRP)-
conjugated anti-mouse antibody (5000 times diluted with PBS; Amer-
sham Biosciences, USA) as a secondary antibody, and 100 Wl of a
substrate solution (100 mM sodium acetate, pH 6) containing
3,3P,5,5P-tetramethylbenzidine (100 Wg/ml) and hydrogen peroxide
(0.6%). The enzyme reaction was stopped by adding 50 Wl of 1 M
H2SO4. The peroxidase activity was evaluated by calculating the dif-
ference in absorbance (A) at 630 nm and 450 nm (A4503A630). An
excess of chlorpropham (10 Wg/ml) was mixed with the soluble protein
extract before the reaction with the coated antigen for competitive
indirect ELISA (ci-ELISA).
The expression of scFv was also detected by Western blotting. A
sample of the amount indicated was applied to sodium dodecyl sul-
fate^polyacrylamide gel electrophoresis. Proteins were electrotrans-
ferred on to a nitrocellulose membrane, and a c-myc tag fused to
scFv was detected with the 9E10 antibody and HRP-conjugated
anti-mouse antibody as for ELISA. The HRP activity was detected
by an ECL Plus Western blotting detection system (Amersham Bio-
sciences).
2.4. Cell fractionation
A microsomal fraction was prepared from whole plants, all proce-
dures being conducted at 4‡C or on ice. Plants were homogenized in
liquid nitrogen, and an extraction bu¡er (100 mM Tris^HCl at pH
7.8, 10 mM KCl, 12% w/v sucrose, 1 mM EDTA and 2 mM MgCl2)
was added at 1 ml/g fresh weight (fw). The homogenate was centri-
fuged at 12 600Ug for 10 min, and the resulting supernatant was
centrifuged at 120 000Ug for 100 min. The microsomal fraction was
prepared by resuspending the resulting pellet in PBS. The soluble
proteins in the remaining supernatant were precipitated with cold
acetone, and the pellet was resuspended in PBS to give the soluble
protein fraction.
The microsomal fraction was used for Triton X-114 phase parti-
tioning as previously described with minor modi¢cations [17]. The
microsomal fraction was equilibrated with a lysis bu¡er (150 mM
NaCl, 2% Triton X-114 and 10 mM Tris^HCl at pH 7.4), incubated
at 32‡C for 12 min and then centrifuged (3000Ug, 32‡C, 3 min). The
detergent phase was resuspended in cold bu¡er A (150 mM NaCl,
0.06% Triton X-114 and 10 mM Tris^HCl at pH 7.4) and incubated
at 0‡C for 10 min. Triton X-114 partitioning was repeated. The de-
tergent phase was then resuspended in bu¡er A, incubated at 0‡C for
10 min, and centrifuged (18 000Ug, 0‡C, 10 min). The resulting super-
natant was again partitioned with Triton X-114. Proteins in the ¢nal
detergent phase and in the aqueous phase from the partitioning steps
were precipitated with cold acetone, resuspended in PBS and applied
to a Western blotting analysis. When the detergent phase was used for
phosphatidylinositol-speci¢c phospholipase C (PI-PLC) treatment, the
pellet from the detergent phase was resuspended in an incubation
bu¡er containing Bacillus thuringiensis PI-PLC (Glyko, Novato, CA,
USA) at 2 U/ml, 0.1% w/v sodium deoxycholate and 100 mM HEPES
(pH 7.2), and then incubated at 37‡C for 3 h. Triton X-114 phase
partitioning was repeated as just described.
2.5. Chlorpropham tolerance test
Seeds of transgenic plants and wild-type plants were surface-steri-
lized, before being planted on MS agar medium containing chlorpro-
pham at the indicated concentrations. The chlorpropham tolerance
was evaluated by measuring the length of the longest leaf in each
plant 10 days after germination.
3. Results
3.1. Transformation of Arabidopsis with the plant expression
vectors
Plant expression vectors pBISER, pBISCY, pBISAP,
pBISGA and pBISGS were constructed for the expression
of scFv in ER, CY and AP, and as a GPI-anchored protein
by respectively using the GPI-addition signals from Arabidop-
sis AGP5 or S. cerevisiae GAS1 (Fig. 1). These constructs were
introduced into Arabidopsis by Agrobacterium-mediated trans-
formation, respectively generating the AER, ACY, AAP,
AGA and AGS transgenic lines. More than 10 initial inde-
pendent transformants (T1) for each construct were selected
by their kanamycin resistance.
3.2. Expression of scFv in the transgenic plants
A protein extract was prepared from the progeny (T2) of 10
independent T1 lines for each construct, and the binding ac-
Fig. 1. Construction of the plant expression vectors. The GPI-addi-
tion signals were isolated from Arabidopsis or S. cerevisiae, giving
two constructs for the expression of scFv as a GPI-anchored pro-
tein. NP, nopaline synthase promoter; NPTII, neomycin phospho-
transferase gene; NT, nopaline synthase terminator; 35S-P, CaMV
35S promoter; LeB4, legumine B4 signal peptide; c-myc, c-myc tag;
KDEL, ER retention signal; GPI, GPI-addition signal; 35S-T,
CaMV 35S terminator.
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tivity of scFv in each extract was examined by i-ELISA. Ac-
tivity toward chlorpropham was detected in the extract of all
the AER, AAP, AGA and AGS plants, while the extract of
any ACY line showed no binding activity. It seems that the
KDEL sequence, which has been reported to stabilize scFv in
cytosol [18], did not work in our case. The reversibility of the
binding was con¢rmed by ci-ELISA for some of the lines (Fig.
2A). The binding of the coating antigen with scFv was clearly
replaced by excess chlorpropham as a competitor. The pro-
duction of scFv in the AER, AAP, AGA and AGS plants was
also con¢rmed by Western blotting (Fig. 3A), as was the ex-
pression level of scFv in the extract of each AER line (Fig.
2B). In both analyses, the highest scFv expression level was
obtained in the AER plants.
3.3. Subcellular localization of scFv
The microsomal fraction and the soluble protein fraction
were prepared by cell fractionation to con¢rm the subcellular
localization of scFv. Western blotting (Fig. 3A) detected scFv
mainly in the microsomal fraction from the AER plants, and
in the microsomal fraction and soluble protein fraction from
the AAP plants. scFv was detected in the microsomal frac-
tions from the AGS and AGA plants.
In order to investigate whether scFv in the microsomal
fractions of AGA and AGS was embedded in the plasma
membrane or anchored to the plasma membrane by a GPI
anchor, the microsomal fraction was used for a further anal-
ysis. After Triton X-114 phase partitioning had been per-
formed, scFv from AGA and AGS was detected in the deter-
gent phase to which GPI-anchored proteins and other
hydrophobic membrane proteins are presumed to have been
partitioned, while scFv from AER and AAP could not be
detected in the detergent phase (Fig. 3B). Treatment with
PI-PLC, which speci¢cally cleaves phosphatidylinositol of a
GPI-anchored protein, and further Triton X-114 phase parti-
tioning shifted scFv in the detergent phase from AGA and
AGS to the aqueous phase, while mock-treated scFv stayed in
the detergent phase (Fig. 3C). This indicates that scFv in
AGA and AGS was expressed as a GPI-anchored protein.
3.4. Chlorpropham tolerance of the transgenic plants
Seeds of the transgenic plants and of the wild-type plant
were planted on MS medium containing 1 Wg/ml of chlorpro-
pham to examine the chlorpropham tolerance. The chlorpro-
pham concentration was determined by cultivating wild-type
plants at various concentrations (shown in Fig. 4E). The
Fig. 2. Expression of scFv in representative transgenic plants. The protein extract was used for these analyses. A: The expression and binding
activity of scFv toward chlorpropham were detected by i- and ci-ELISA. Chlorpropham was not added for i-ELISA [chlorpropham(3)], and
an excess of chlorpropham (10 Wg/ml) was added for ci-ELISA as a competitor [chlorpropham(+)]. B: The expression of scFv was also con-
¢rmed by Western blotting. 30 Wg protein was loaded for each lane. Numbers indicate the T2 progeny from independent T1 transformant lines.
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wild-type plants showed obvious sensitivity to chlorpropham
10 days after germination: the leaves had curled and the de-
velopment was strongly inhibited. Of ¢ve AER T2 plants
examined (the progeny of T1 lines AER1, 2, 3, 4 and 5),
many plants in all the lines grew bigger than the wild-type
under the same condition as shown in Fig. 4A, while all plants
of the AAP, AGA and AGS lines were equally sensitive to
chlorpropham as the wild-type (data not shown). The toler-
ance was evaluated as the length of the longest leaf in each
plant (Fig. 4B). The values for the AER lines showed a sig-
ni¢cant di¡erence from those of the wild-type plants when
cultivated with chlorpropham. Thus, the AER lines showed
obvious tolerance to chlorpropham in comparison with the
wild-type plants. Although the AER plants were not fully
tolerant to chlorpropham, their leaves did not curl and they
grew to maturity, while the wild-type plants did not survive
(Fig. 4C). To provide a detailed analysis of the phenotype,
homozygous T3 lines were established from each independent
T2 (AER1^3 and AER4^5) by testing their kanamycin resis-
tance. They showed a more homogeneous distribution of the
longest leaf length than the heterozygous lines (Fig. 4D). The
dose^response characteristics to chlorpropham were com-
pared between the wild-type and one of the homozygous lines,
AER4^5 (Fig. 4E). The results show that the reagent was
toxic at a concentration higher than 0.32 Wg/ml for both the
wild-type and AER4^5 plants, but the latter had better
growth in the concentration range of 0.32^1.0 Wg/ml. Within
this range, AER4^5 showed comparable growth to the wild-
type plants at about a two-fold higher concentration of chlor-
propham.
4. Discussion
Transgenic plants expressing anti-chlorpropham scFv in
di¡erent cellular compartments (ER, CY and AP) and as a
GPI-anchored protein were prepared. Functional scFv expres-
sion in the transgenic plants was achieved by targeting scFv
into ER and AP; targeting into CY did not accumulate scFv
at a detectable level, this being a similar pattern to that re-
ported elsewhere [4,19]. We also succeeded for the ¢rst time in
expressing scFv in a GPI-anchored form. The results of cell
fractionation provide strong evidence to prove that scFv was
localized to ER in the AER plants, to AP in the AAP plants,
and to the plasma membrane in the AGA and AGS plants.
scFv in the AER plants was designed to be transported into
the lumen of ER under the direction of the LeB4 signal pep-
tide and retained in ER by the KDEL sequence; the highest
level of scFv accumulation would have been due to the envi-
ronment of ER that is favorable for the folding of scFvs [20].
The AER lines showed enhanced tolerance to chlorpropham.
This tolerance was to some extent correlated with the expres-
sion level and binding activity of scFv; the expression level
and binding activity of scFv were relatively low in the AER3
plants which showed less tolerance than the other AER lines.
It can be deduced that, in the cells of AER plants, chlorpro-
pham passed through the ER membrane, and was captured by
scFv that had accumulated in ER, resulting in a decreased
intracellular chlorpropham concentration.
We successfully expressed scFv with antigen-binding activ-
ity as a GPI-anchored protein by using GPI-addition signals.
Takos et al. have reported that the yeast GPI-addition signal
from GAS1 and the putative plant GPI-addition signal from
LeAGP-1 were capable of directing the addition of a GPI
anchor to a reporter protein [14]. In this present study, the
GPI-addition signals isolated from A. thaliana AGP5 and
S. cerevisiae GAS1 were used for the expression of scFv as
a GPI-anchored protein. The results of Triton X-114 phase
partitioning and PI-PLC treatment reveal that the GPI-addi-
tion signal from A. thaliana AGP5 as well as that from
S. cerevisiae GAS1 functioned to link scFv to the plasma
membrane by the GPI anchor.
The AAP, AGA and AGS plants had no enhanced toler-
ance to chlorpropham, indicating that scFv expressed in AP
or on the cell surface was not able to successfully prevent
chlorpropham from entering the cells. Thus, an enhanced tol-
erance to chlorpropham was only obtained when the scFv
expression was targeted to ER. Considering the correlation
between the scFv level and the tolerance to chlorpropham
among di¡erent AER lines (Figs. 2B and 4B) and among
the transgenic plants with di¡erent scFv compartments, the
expression level of scFv seems to have been the key factor for
Fig. 3. Subcellular localization of scFv. The scFv localization was
detected by Western blotting after each fractionation. A: The micro-
somal fraction was prepared by ultracentrifugation of the cell ho-
mogenate. E, protein extract from 10 mg fw; M, microsomal frac-
tion from 100 mg fw; S, soluble protein fraction from 100 mg fw.
B: The GPI-anchored protein and other hydrophobic proteins were
extracted in the detergent phase by Triton X-114 phase partitioning.
D, detergent phase; A, aqueous phase equivalent to 100 mg fw.
C: The detergent phase was incubated in the absence (3PI-PLC) or
presence (+PI-PLC) of PI-PLC, and Triton X-114 phase partitioning
was repeated. D, detergent phase; A, aqueous phase equivalent to
100 mg fw.
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the tolerance. It is also possible, however, that the environ-
ment of each cell compartment a¡ected the functionality of
scFv; binding activity and/or accessibility of scFv to chlor-
propham may vary due to the di¡erent environments.
There are some potential applications from the results of
this study. Since the agent neutralizing the action of the her-
bicide with this approach was an antibody fragment, the
method can be applied to many other herbicides for a diverse
range of antibodies, and the tolerance can be improved by
engineering the antigen-binding activity. The antibody-pro-
ducing plants could be utilized for phytoremediation by their
ability to capture herbicides in the environment [21].
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Fig. 4. Chlorpropham tolerance of the transgenic plants. A: 10-day-old plants of the wild-type and T2 heterozygous (progeny of AER5) lines
cultivated on MS medium containing no or 1 Wg/ml of chlorpropham. B: Distribution of the longest leaf length in each plant of the wild-type
and T2 progeny from the T1 AER lines (#1^5) cultivated on MS medium containing 1 Wg/ml of chlorpropham. Each value represents the
mean of the leaf lengthUS.D. C: 24-day-old plants of the wild-type and T2 progeny of the AER4 line cultivated on MS medium containing
1 Wg/ml of chlorpropham. Bars= 1 cm. D: Distribution of the longest leaf length in each plant of the wild-type and T3 homozygous lines culti-
vated on MS medium containing 1 Wg/ml of chlorpropham. Each value represents the mean of the leaf lengthUS.D. E: Comparison of the
dose^response curves between the wild-type plants and T3 homozygous progeny from AER4^5 against di¡erent concentrations of chlor-
propham.
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